AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34791771 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-plant extracts product (oral intake for 12 weeks)
Number of subjects: 55
Study 34791771 — intervention group
Group type: COMPARATOR
Intervention: UV+high dose group (0.500 g/kg.BW)
Number of subjects: 55
Study 34791771 — intervention group
Group type: COMPARATOR
Intervention: UV+moderate dose group (0.250 g/kg.BW)
Number of subjects: 55
Study 34791771 — intervention group
Group type: COMPARATOR
Intervention: UV+low dose group (0.125 g/kg.BW)
Number of subjects: 55
Study 34791771 — intervention group
Group type: COMPARATOR
Intervention: UV+high and moderate dose groups
Number of subjects: 55
Study 34144852 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV vaccination program in schools
Number of subjects: 221
Study 32508043 — intervention group
Group type: EXPERIMENTAL
Intervention: Video educational tool
Number of subjects: 150
Study 32508043 — intervention group
Group type: COMPARATOR
Intervention: Verbal description of hospice
Number of subjects: 150
Study 33766074 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (detailed dosage not specified)
Number of subjects: 816
Study 33780928 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mL of water every 2 hours (1,600 mL per day)
Number of subjects: 92
Study 33780928 — intervention group
Group type: COMPARATOR
Intervention: 100 mL of water every 2 hours (800 mL per day)
Number of subjects: 92
Study 33780928 — intervention group
Group type: EXPERIMENTAL
Intervention: 110 mL of water every 1 hour (1,650 mL per day)
Number of subjects: 92
Study 34000987 — intervention group
Group type: EXPERIMENTAL
Intervention: Lighted stylet bent at 70 degrees
Number of subjects: 0
Study 34000987 — intervention group
Group type: EXPERIMENTAL
Intervention: Lighted stylet bent at 80 degrees
Number of subjects: 0
Study 34000987 — intervention group
Group type: EXPERIMENTAL
Intervention: Lighted stylet bent at 90 degrees
Number of subjects: 0
Study 32819928 — intervention group
Group type: EXPERIMENTAL
Intervention: ENACT (Environmental enrichment for infants; parenting with Acceptance and Commitment Therapy)
Number of subjects: 66
Study 32819928 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 66
Study 34873117 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy protocol based on physical exercise
Number of subjects: 20
Study 34873117 — intervention group
Group type: COMPARATOR
Intervention: Hospital's physical therapy protocol
Number of subjects: 20
Study 32706812 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention (LI)
Number of subjects: 204
Study 32706812 — intervention group
Group type: COMPARATOR
Intervention: Health and Wellness (HW)
Number of subjects: 204
Study 35777155 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Almond Shell-based Biochar (ASB)
Number of subjects: 3
Study 35777155 — intervention group
Group type: EXPERIMENTAL
Intervention: Almond Shell (AS) and Almond Shell-based Biochar (ASB) in different mass ratios (5%, 10%, 15%)
Number of subjects: 3
Study 35777155 — intervention group
Group type: COMPARATOR
Intervention: Control (no amendment)
Number of subjects: 3
Study 33412262 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-fraction SBRT (48.5 Gy in 10 fractions)
Number of subjects: 57
Study 33412262 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fraction SBRT (35 Gy in 5 fractions)
Number of subjects: 57
Study 33412262 — intervention group
Group type: EXPERIMENTAL
Intervention: Both 10-fraction and 5-fraction SBRT
Number of subjects: 57
Study 32312838 — intervention group
Group type: EXPERIMENTAL
Intervention: CRISPR/Cas9 mediated activation of gene expression to select for loss-of-function alleles
Number of subjects: 45000
Study 35582999 — intervention group
Group type: COMPARATOR
Intervention: Mometasone nasal spray for four weeks (M)
Number of subjects: 40
Study 35582999 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone nasal spray plus oral commercially available quail egg and zinc tablets (M+N)
Number of subjects: 40
Study 34453268 — intervention group
Group type: EXPERIMENTAL
Intervention: Community service-linkage model to evidence-based programs (targeted provider outreach)
Number of subjects: 4873
Study 34453268 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control group)
Number of subjects: 4873
Study 32503041 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of cooking ash
Number of subjects: 0
Study 32503041 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of boiling water
Number of subjects: 0
Study 32503041 — intervention group
Group type: COMPARATOR
Intervention: Neither intervention (control group)
Number of subjects: 0
Study 616463931 — intervention group
Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 0
Study 616463931 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 0
Study 35318738 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g rosemary leaf powder
Number of subjects: 110
Study 35318738 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch) powders
Number of subjects: 110
Study 34920968 — intervention group
Group type: EXPERIMENTAL
Intervention: H2GO! intervention (usual BGC programming plus H2GO!)
Number of subjects: 100
Study 34920968 — intervention group
Group type: COMPARATOR
Intervention: Usual BGC programming (control group)
Number of subjects: 100
Study 32379496 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 Doing Well app
Number of subjects: 80
Study 32379496 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care (control)
Number of subjects: 80
Study 35559526 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical reflection blended with technology (Group C)
Number of subjects: 150
Study 35559526 — intervention group
Group type: EXPERIMENTAL
Intervention: Video recording of role-play (Group B)
Number of subjects: 150
Study 35559526 — intervention group
Group type: COMPARATOR
Intervention: Conventional practical demonstration (Group A)
Number of subjects: 150
Study 34186281 — intervention group
Group type: EXPERIMENTAL
Intervention: O3-AHT (Ozone autohemotherapy)
Number of subjects: 92
Study 34186281 — intervention group
Group type: COMPARATOR
Intervention: SoC (Standard of Care)
Number of subjects: 92
Study 35026491 — intervention group
Group type: EXPERIMENTAL
Intervention: iCanQuit
Number of subjects: 897
Study 35026491 — intervention group
Group type: COMPARATOR
Intervention: QuitGuide
Number of subjects: 897
Study 35701242 — intervention group
Group type: EXPERIMENTAL
Intervention: Posture-cueing shirt
Number of subjects: 30
Study 35701242 — intervention group
Group type: COMPARATOR
Intervention: No shirt
Number of subjects: 30
Study 35701242 — intervention group
Group type: COMPARATOR
Intervention: Compression shirt
Number of subjects: 30
Study 32048336 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) study
Number of subjects: 0
Study 35107239 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) treatment for ovarian rejuvenation
Number of subjects: 0
Study 32122322 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored leaflet intervention
Number of subjects: 129
Study 32122322 — intervention group
Group type: COMPARATOR
Intervention: Usual care control (no leaflet)
Number of subjects: 129
Study 34533973 — intervention group
Group type: EXPERIMENTAL
Intervention: FU/FA plus Pmab
Number of subjects: 248
Study 34533973 — intervention group
Group type: COMPARATOR
Intervention: FU/FA alone
Number of subjects: 248
Study 32306634 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise-exposure + doxycycline (50 mg/kg/d for 4 consecutive days)
Number of subjects: 45
Study 32306634 — intervention group
Group type: COMPARATOR
Intervention: Noise-exposure (120 dB SPL white noise for 4 h per day for 2 consecutive days)
Number of subjects: 45
Study 32306634 — intervention group
Group type: COMPARATOR
Intervention: Normal control (0.9% saline for 4 consecutive days)
Number of subjects: 45
Study 32306634 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise-exposure + doxycycline
Number of subjects: 45
Study 32306634 — intervention group
Group type: COMPARATOR
Intervention: Noise-exposure
Number of subjects: 45
Study 33543266 — intervention group
Group type: EXPERIMENTAL
Intervention: Denneroll cervical traction
Number of subjects: 110
Study 33543266 — intervention group
Group type: COMPARATOR
Intervention: Multimodal program (Control)
Number of subjects: 110
Study 33028101 — intervention group
Group type: EXPERIMENTAL
Intervention: PZ‐128 (0.3 or 0.5 mg/kg)
Number of subjects: 100
Study 33028101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33028101 — intervention group
Group type: EXPERIMENTAL
Intervention: PZ‐128 (combined doses)
Number of subjects: 100
Study 35021600 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular lymphoma grade 3B with coexisting diffuse large B-cell lymphoma
Number of subjects: 0
Study 35021600 — intervention group
Group type: COMPARATOR
Intervention: Follicular lymphoma grade 3B without coexisting diffuse large B-cell lymphoma
Number of subjects: 0
Study 33787625 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free gum, chewed for 6 hours post-surgery until first intestinal gas release
Number of subjects: 74
Study 33787625 — intervention group
Group type: COMPARATOR
Intervention: Water consumption after 6 hours post-surgery
Number of subjects: 74
Study 34549852 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally non-adapted unguided internet-based sleep intervention (3 modules on sleep hygiene and cognitive techniques)
Number of subjects: 81
Study 34549852 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 81
Study 33208752 — intervention group
Group type: EXPERIMENTAL
Intervention: SAFER pregnancy intervention (monthly group sessions, web-based platform, incentives for cessation)
Number of subjects: 66
Study 33208752 — intervention group
Group type: EXPERIMENTAL
Intervention: SAFER pregnancy intervention
Number of subjects: 66
Study 35121638 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic monitoring feedback (EMF) with a Medication Event Monitoring System (MEMS) cap and motivational interviewing feedback.
Number of subjects: 206
Study 35121638 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group).
Number of subjects: 206
Study 35121638 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic monitoring feedback (EMF) for bDMARD-naive patients.
Number of subjects: 206
Study 35121638 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic monitoring feedback (EMF).
Number of subjects: 206
Study 33811783 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma neurofilament light chain (NfL) levels
Number of subjects: 115
Study 32540806 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index/high-fat, high-calorie diet
Number of subjects: 44
Study 32540806 — intervention group
Group type: COMPARATOR
Intervention: High-fat, high-calorie diet
Number of subjects: 44
Study 35113809 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical metronidazole treatment
Number of subjects: 0
Study 33158697 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 12806
Study 33158697 — intervention group
Group type: COMPARATOR
Intervention: Non-montelukast
Number of subjects: 12806
Study 32128884 — intervention group
Group type: EXPERIMENTAL
Intervention: DBBM-C/CM
Number of subjects: 36
Study 32128884 — intervention group
Group type: EXPERIMENTAL
Intervention: DBBM-C
Number of subjects: 36
Study 32128884 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous Healing (SH)
Number of subjects: 36
Study 35130768 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 132
Study 35130768 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 132
Study 34422076 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 60
Study 34292430 — intervention group
Group type: EXPERIMENTAL
Intervention: Family planning support intervention
Number of subjects: 320
Study 34331914 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoembolization
Number of subjects: 209
Study 34331914 — intervention group
Group type: EXPERIMENTAL
Intervention: Yttrium‐90 radioembolization
Number of subjects: 209
Study 34331914 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial downstaging procedure
Number of subjects: 209
Study 34331914 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-LT survival
Number of subjects: 209
Study 34331914 — intervention group
Group type: EXPERIMENTAL
Intervention: HCC recurrence
Number of subjects: 209
Study 34331914 — intervention group
Group type: EXPERIMENTAL
Intervention: Sum of the number of lesions plus largest tumor diameter on the last pre‐LT imaging
Number of subjects: 209
Study 34331914 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment with lectin-reactive ?-fetoprotein ?10%
Number of subjects: 209
Study 35981712 — intervention group
Group type: EXPERIMENTAL
Intervention: blackcurrant + caffeine
Number of subjects: 12
Study 35981712 — intervention group
Group type: EXPERIMENTAL
Intervention: blackcurrant + placebo
Number of subjects: 12
Study 35981712 — intervention group
Group type: EXPERIMENTAL
Intervention: caffeine + placebo
Number of subjects: 12
Study 35981712 — intervention group
Group type: COMPARATOR
Intervention: placebo + placebo
Number of subjects: 12
Study 33174483 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS at 1.0 mA
Number of subjects: 123
Study 33174483 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS at 0.7 mA
Number of subjects: 123
Study 33174483 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS at 2.0 mA
Number of subjects: 123
Study 33174483 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 123
Study 36378018 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle-free insulin injector (NFII)
Number of subjects: 48
Study 36378018 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin pen (CIP)
Number of subjects: 48
Study 32162352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitacoxib (0.1 mg/kg)
Number of subjects: 6
Study 32162352 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral paste vitacoxib (0.1 mg/kg)
Number of subjects: 6
Study 32162352 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tablet vitacoxib (0.1 mg/kg)
Number of subjects: 6
Study 33678253 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent moisturizer use
Number of subjects: 1303
Study 35796481 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (3.3-3.9 g/day)
Number of subjects: 314
Study 35796481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study 34142950 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic clozapine (ChangZhou Pharmaceutical Factory Co. Ltd.) 100 mg twice daily for 10 days
Number of subjects: 26
Study 34142950 — intervention group
Group type: COMPARATOR
Intervention: Clozaril (HLS Therapeutics, Inc.) 100 mg twice daily for 10 days
Number of subjects: 26
Study 32301812 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow speed stripping (group 1)
Number of subjects: 20
Study 32301812 — intervention group
Group type: COMPARATOR
Intervention: Fast speed stripping (group 2)
Number of subjects: 20
Study 36018883 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic needle tip positioning (DNTP)
Number of subjects: 151
Study 32157905 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 200
Study 32157905 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 200
Study 34514626 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of CHNA as 'not troublesome' or 'not impossible as they learned'
Number of subjects: 3397
Study 34514626 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing education with 5 years of experience
Number of subjects: 3397
Study 34514626 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of the learned model in continuing education
Number of subjects: 3397
Study 34514626 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for non-utilization of the model
Number of subjects: 3397
Study 33308949 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal Inlay Graft Urethroplasty (DIGU)
Number of subjects: 39
Study 33308949 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal Onlay Preputial Flap (LOF)
Number of subjects: 39
Study 35610366 — intervention group
Group type: COMPARATOR
Intervention: E-T-CMF (Control Arm A)
Number of subjects: 990
Study 35610366 — intervention group
Group type: EXPERIMENTAL
Intervention: E-CMF-wD (Arm B)
Number of subjects: 990
Study 35610366 — intervention group
Group type: EXPERIMENTAL
Intervention: E-CMF-wT (Arm C)
Number of subjects: 990
Study 35610366 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab administration
Number of subjects: 990
Study 35610366 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 990
Study 33189637 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecytology quality assurance program
Number of subjects: 1983
Study 36040069 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 210
Study 36040069 — intervention group
Group type: COMPARATOR
Intervention: Control (standard of care)
Number of subjects: 210
Study 34706374 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA1 (1000 mL with approximately 200,000 µg silicon/L)
Number of subjects: 12
Study 34706374 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA2 (1000 mL with approximately 750,000 µg silicon/L)
Number of subjects: 12
Study 34706374 — intervention group
Group type: COMPARATOR
Intervention: Si-low-Water (approximately 10-10,000 µg silicon/L as a control)
Number of subjects: 12
Study 33998393 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercises
Number of subjects: 75
Study 33998393 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercises
Number of subjects: 75
Study 33998393 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 33451926 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfaxalone (15 mg kg−1) and midazolam (2 mg kg−1) with flumazenil (0.3 mg kg−1)
Number of subjects: 10
Study 33451926 — intervention group
Group type: COMPARATOR
Intervention: Alfaxalone (15 mg kg−1) and midazolam (2 mg kg−1) with saline
Number of subjects: 10
Study 32779560 — intervention group
Group type: EXPERIMENTAL
Intervention: Rare indications
Number of subjects: 96
Study 32779560 — intervention group
Group type: COMPARATOR
Intervention: Non-rare indications
Number of subjects: 96
Study 32779560 — intervention group
Group type: EXPERIMENTAL
Intervention: Funding time
Number of subjects: 96
Study 35633281 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention (details not specified)
Number of subjects: 157
Study 32945236 — intervention group
Group type: EXPERIMENTAL
Intervention: Agrochemical health education intervention
Number of subjects: 480
Study 32945236 — intervention group
Group type: COMPARATOR
Intervention: Inappropriate time of spray
Number of subjects: 480
Study 32945236 — intervention group
Group type: COMPARATOR
Intervention: Frequency of spray
Number of subjects: 480
Study 32945236 — intervention group
Group type: COMPARATOR
Intervention: Long hours of daily chemical spray
Number of subjects: 480
Study 32945236 — intervention group
Group type: COMPARATOR
Intervention: Non-usage of chemical labels
Number of subjects: 480
Study 32101915 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy first (group A)
Number of subjects: 54
Study 32101915 — intervention group
Group type: COMPARATOR
Intervention: Brushings first (group B)
Number of subjects: 54
Study 32101915 — intervention group
Group type: COMPARATOR
Intervention: Combination (group C)
Number of subjects: 54
Study 34718171 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (HT)
Number of subjects: 100
Study 34718171 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment (SMT)
Number of subjects: 100
Study 33634706 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation
Number of subjects: 346
Study 35109685 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment group (ΔSBP15-60M)
Number of subjects: 267
Study 35109685 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment group (ΔSBP6-24H)
Number of subjects: 267
Study 35109685 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 267
Study 32060747 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy with 3D visualization technology
Number of subjects: 135
Study 32060747 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic appendectomy with standard 2D technology
Number of subjects: 135
Study 32060747 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy with 3D visualization technology (subgroup of complicated appendicitis)
Number of subjects: 135
Study 32060747 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic appendectomy with standard 2D technology (subgroup of complicated appendicitis)
Number of subjects: 135
Study 35697450 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised education using a smart spacer (Aerochamber Plus with Flow Vu) for 1 month
Number of subjects: 40
Study 35697450 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 40
Study 35697450 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall feasibility of a definitive trial
Number of subjects: 40
Study 35697450 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient and healthcare provider satisfaction
Number of subjects: 40
Study 32721163 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) for weight loss
Number of subjects: 134
Study 32721163 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 134
Study 32319514 — intervention group
Group type: EXPERIMENTAL
Intervention: Special home visiting support
Number of subjects: 1510
Study 35870556 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary Angiography (CAG)
Number of subjects: 24
Study 33984038 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF)
Number of subjects: 275
Study 33984038 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 275
Study 36394733 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue photosensitizer (MBP) + MTAD
Number of subjects: 40
Study 36394733 — intervention group
Group type: EXPERIMENTAL
Intervention: Rose Bengal photosensitizer (RBP) + MTAD
Number of subjects: 40